Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

Using stem cells from fat tissue can significantly improve wound healing in dogs.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

Early treatment with the right dose of stem cells can reduce lupus symptoms.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

Green tea component EGCG helps keep rat skin grafts viable longer.

Graft rejection in a hand transplant may trigger hair loss due to autoimmune responses.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

GFP transgenic mice help study cell origins in skin grafts.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

New methods for skin and nerve regeneration can improve healing and feeling after burns.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

The document concludes that careful surgical methods and choosing the right materials are key for successful scalp, skull, and frontal sinus reconstruction.